Shehnaaz Suliman insider trades: 10x Genomics (TXG) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shehnaaz reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | TXG | ↓ Sell | 5,723 | $81.19 | $465K | Direct | Sep 24, 2026 (2d) |
| Aug 24, 2026 | TXG | ↓ Sell | 2,207 | $63.65 | $140K | Direct | Aug 26, 2026 (2d) |
| Jun 16, 2026 | TXG | ↓ Sell | 5,723 | $32.63 | $187K | Direct | Jun 18, 2026 (2d) |
| May 18, 2026 | RARE | ↓ Sell | 5,740 | $25.12 | $144K | Direct | May 18, 2026 (0d) |
| Dec 13, 2021 | ALEC | ↓ Sell | 150,000 | $21.50 | $3.2M | Direct | Dec 14, 2021 (1d) |
| Dec 9, 2021 | ALEC | ↓ Sell | 150,000 | $22.81 | $3.4M | Direct | Dec 10, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TXG insiders
Open-market trades in the last 12 months
About Shehnaaz Suliman's insider trades
Shehnaaz Suliman is an insider at 10x Genomics (TXG). Since Dec 9, 2021, Shehnaaz has reported no open-market purchases and 6 sales worth $7.6M on SEC Form 4. In the last 12 months: 4 sales ($936K).
Their filings also include grants and awards (21 filings), option exercises (2 filings), shares withheld for taxes (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.